Precision cardiovascular medicine: shifting the innovation paradigm

Area of Science:

• Cardiovascular Medicine
• Biomedical Research
• Precision Medicine

Background:

• Cardiovascular diseases (CVDs) are the leading global cause of death despite advances in treatment.
• Multilevel heterogeneity in CVDs, from molecular mechanisms to clinical presentation, presents a significant challenge.
• Individual variability, influenced by genomic and exposomic factors, necessitates precision-based approaches.

Purpose of the Study:

• To explore how novel technologies can address challenges in cardiovascular disease therapy.
• To highlight the potential of integrative precision medicine for improving global health outcomes.
• To discuss the role of systems biology and network medicine in advancing cardiovascular research.

Main Methods:

• Application of artificial intelligence (AI) to large datasets, including clinical information and multiomics data (genomics, transcriptomics, proteomics, metabolomics).
• Utilizing systems biology and network medicine to elucidate complex disease mechanisms.
• Employing new computational approaches to translate discoveries into therapies and overcome drug development barriers.

Main Results:

• AI and multiomics analysis can uncover disease mechanisms, identify novel biomarkers, and pinpoint potential drug targets for CVDs.
• Computational methods aid in developing new therapies and addressing the "druggability" of identified targets.
• An integrative precision medicine approach shows promise for more effective cardiovascular treatments.

Conclusions:

• A shift towards a precision-based paradigm in cardiovascular medicine requires enhanced interdisciplinary collaboration and data science integration.
• New partnerships between academia and industry are crucial for translating research into clinical practice.
• Global policy and leadership are essential for funding, data infrastructure, regulatory frameworks, and equitable patient access to innovative therapies.